Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
- A. Wolff, M. Hammond, +17 authors D. Hayes
- Medicine
- Archives of pathology & laboratory medicine
- 1 February 2014
PURPOSE
To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing in… Expand
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
- M. Cristofanilli, G. Budd, +8 authors D. Hayes
- Medicine
- The New England journal of medicine
- 19 August 2004
BACKGROUND
We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer.
METHODS
In a prospective, multicenter study, we tested 177 patients… Expand
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
- A. Wolff, M. Hammond, +20 authors D. Hayes
- Medicine
- Journal of clinical oncology : official journal…
- 20 January 2006
PURPOSE
To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker.
METHODS
The… Expand
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
- A. Wolff, M. Hammond, +20 authors D. Hayes
- Medicine
- Archives of pathology & laboratory medicine
- 2007
PURPOSE
To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2(HER2) testing in invasive breast cancer and its utility as a predictive marker.
METHODS
The… Expand
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- A. Goldhirsch, E. Winer, +55 authors W. Wood
- Medicine
- Annals of oncology : official journal of the…
- 4 August 2013
The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer,… Expand
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
- M. Hammond, D. Hayes, +29 authors A. Wolff
- Medicine
- Journal of clinical oncology : official journal…
- 1 June 2010
PURPOSE
To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the utility of these receptors… Expand
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
- M. Dowsett, T. Nielsen, +18 authors D. Hayes
- Medicine
- Journal of the National Cancer Institute
- 16 November 2011
Uncontrolled proliferation is a hallmark of cancer. In breast cancer, immunohistochemical assessment of the proportion of cells staining for the nuclear antigen Ki67 has become the most widely used… Expand
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
- G. Locker, S. Hamilton, +6 authors R. Bast
- Medicine
- Journal of clinical oncology : official journal…
- 20 November 2006
PURPOSE
To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of gastrointestinal cancers.
METHODS
For the 2006 update, an update… Expand
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
- Y. Jin, Z. Desta, +16 authors D. Flockhart
- Biology, Medicine
- Journal of the National Cancer Institute
- 5 January 2005
BACKGROUND
The efficacy of tamoxifen therapy for the treatment of breast cancer varies widely among individuals. Plasma concentrations of the active tamoxifen metabolite endoxifen are associated with… Expand
Revision of the American Joint Committee on Cancer staging system for breast cancer.
- S. Singletary, C. Allred, +17 authors F. Greene
- Medicine
- Journal of clinical oncology : official journal…
- 1 September 2002
PURPOSE
To revise the American Joint Committee on Cancer staging system for breast carcinoma.
MATERIALS AND METHODS
A Breast Task Force submitted recommended changes and additions to the existing… Expand
...
1
2
3
4
5
...